Explore E2F1 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Introcelluar Protein.
The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein and another 2 members, E2F2 and E2F3, have an additional cyclin binding domain. This protein binds preferentially to retinoblastoma protein pRB in a cell-cycle dependent manner. It can mediate both cell proliferation and p53-dependent/independent apoptosis. [provided by RefSeq, Jul 2008]
| Target ID |
GM-T57059
|
| Target Name |
E2F1
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
1869
|
| Gene ID |
100069192 (Equus caballus), 101098454 (Felis catus), 13555 (Mus musculus), 1869 (Homo sapiens) 399489 (Rattus norvegicus), 485839 (Canis lupus familiaris), 535369 (Bos taurus), 714126 (Macaca mulatta)
|
| Target Alternative Names |
E2F-1,E2F1,E2f1,PBR3,RBAP1,RBBP3,RBP3,Retinoblastoma-associated protein 1 (RBAP-1),Retinoblastoma-binding protein 3 (RBBP-3),Tg(Wnt1-cre)2Sor,Transcription factor E2F1,mKIAA4009,pRB-binding protein E2F-1
|
| Uniprot Accession |
Q61501,Q01094,O09139
|
| Protein Sub-location |
Introcelluar Protein
|
| Category |
Therapeutics Target
|
| Disease |
cancer
|
| Disease from KEGG |
Endocrine resistance, Cellular senescence, Cushing syndrome, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Epstein-Barr virus infection, Pathways in cancer, Chemical carcinogenesis - receptor activation, Pancreatic cancer, Glioma, Prostate cancer, Melanoma, Bladder cancer, Chronic myeloid leukemia, Small cell lung cancer, Non-small cell lung cancer, Breast cancer, Hepatocellular carcinoma, Gastric cancer
|
| Gene Ensembl |
ENSECAG00000012086, ENSMUSG00000027490, ENSG00000101412, ENSCAFG00845025182, ENSBTAG00000003971, ENSMMUG00000023550
|
| Target Classification |
Tumor-associated antigen (TAA)
|
Pre-made viral vector of E2F1 cDNA Clones/ORF Plasmid
E2F1 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo1869 | Pre-made Human E2F1/RBP3/E2F-1 siRNA oligo Duplex | 1869 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo399489 | Pre-made Rat E2f1 siRNA oligo Duplex | 399489 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo13555 | Pre-made Mouse E2f1/E2F-1/mKIAA4009 siRNA oligo Duplex | 13555 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo714126 | Pre-made Cynomolgus/Rhesus macaque E2F1 siRNA oligo Duplex | 714126 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101098454 | Pre-made Cat/Feline E2F1 siRNA oligo Duplex | 101098454 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo485839 | Pre-made Dog/Canine E2F1 siRNA oligo Duplex | 485839 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo535369 | Pre-made Bovines/Cattle E2F1 siRNA oligo Duplex | 535369 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100069192 | Pre-made Equine/Horse E2F1 siRNA oligo Duplex | 100069192 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
E2F1 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T57059-Ab | Human | Anti-Human E2F1 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-rg-T57059-Ab | Rat | Anti-Rat E2F1 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-mg-T57059-Ab | Mouse | Anti-Mouse E2F1 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T57059-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque E2F1 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-felg-T57059-Ab | Cat/Feline | Anti-Cat/Feline E2F1 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-cang-T57059-Ab | Dog/Canine | Anti-Dog/Canine E2F1 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T57059-Ab | Bovines/Cattle | Anti-Bovines/Cattle E2F1 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-equg-T57059-Ab | Equine/Horse | Anti-Equine/Horse E2F1 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
E2F1 recombinant protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T57059-Ag | Human | Human E2F1 recombinant protein | Mammalian cell | Detail |
| GM-Tg-rg-T57059-Ag | Rat | Rat E2F1 recombinant protein | Mammalian cell | Detail |
| GM-Tg-mg-T57059-Ag | Mouse | Mouse E2F1 recombinant protein | Mammalian cell | Detail |
| GM-Tg-cynog-T57059-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque E2F1 recombinant protein | Mammalian cell | Detail |
| GM-Tg-felg-T57059-Ag | Cat/Feline | Cat/Feline E2F1 recombinant protein | Mammalian cell | Detail |
| GM-Tg-cang-T57059-Ag | Dog/Canine | Dog/Canine E2F1 recombinant protein | Mammalian cell | Detail |
| GM-Tg-bovg-T57059-Ag | Bovines/Cattle | Bovines/Cattle E2F1 recombinant protein | Mammalian cell | Detail |
| GM-Tg-equg-T57059-Ag | Equine/Horse | Equine/Horse E2F1 recombinant protein | Mammalian cell | Detail |